A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
- Conditions
- Bone Mineral Density
- Interventions
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2014-10-22
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 1361
- Registration Number
- NCT00924560
- Locations
- 🇺🇸
Teva Investigational Site 025, Torrance, California, United States
🇺🇸Teva Investigational Site 033, Cleveland, Ohio, United States
🇺🇸Teva Investigational Site 013, San Diego, California, United States
A Safety Extension Study of DR-OXY-301
- Conditions
- Overactive Bladder
- Interventions
- Drug: Oxybutinyn Vaginal Ring 4mgDrug: Oxybutinyn Vaginal Ring 6mg
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 240
- Registration Number
- NCT00782769
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
- Conditions
- Migraine
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 109
- Registration Number
- NCT00781456
- Locations
- 🇺🇸
Teva Investigational Site, Houston, Texas, United States
🇺🇸Duramed Investigational Site, Seattle, Washington, United States
Emergency Contraception Actual Use Study
- Conditions
- Emergency Contraception
- Interventions
- Drug: DR-104
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 343
- Registration Number
- NCT00777556
- Locations
- 🇺🇸
Duramed Research Investigational Site, Philadelphia, Pennsylvania, United States
🇺🇸Teva Investigational Site, Pittsburgh, Pennsylvania, United States
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
- Conditions
- Overactive Bladder
- Interventions
- Drug: DR-3001Drug: Placebo
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 1104
- Registration Number
- NCT00685113
- Locations
- 🇨🇦
Duramed Investigational Site, Thunder Bay, Ontario, Canada
🇺🇸Duramed Investigation Site, Decatur, Georgia, United States
🇨🇦Duramed Investigatinal Site, Vancouver, British Columbia, Canada
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2013-09-13
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 1297
- Registration Number
- NCT00615251
- Locations
- 🇺🇸
Duramed Investigational Site, Norfolk, Virginia, United States
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
- First Posted Date
- 2008-01-14
- Last Posted Date
- 2013-07-19
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 157
- Registration Number
- NCT00592839
- Locations
- 🇺🇸
Duramed Investigational Site, San Antonio, Texas, United States
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
- Conditions
- Breakthrough Bleeding
- Interventions
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 567
- Registration Number
- NCT00394771
- Locations
- 🇺🇸
Duramed Investigational Site, Williston, Vermont, United States
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
- Conditions
- Respiratory Tract Diseases
- Interventions
- Biological: DR-5001Other: Placebo
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 4040
- Registration Number
- NCT00382408
- Locations
- 🇺🇸
Duramed Investigational Site, Fort Jackson, South Carolina, United States
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
- Conditions
- Contraception
- Interventions
- Drug: DR-1021
- First Posted Date
- 2006-08-10
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 1347
- Registration Number
- NCT00362479
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States